nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—PTGS2—lung cancer	0.383	1	CbGaD
Icosapent—PTGS2—Cisplatin—lung cancer	0.0235	0.356	CbGbCtD
Icosapent—PTGS2—Etoposide—lung cancer	0.0231	0.349	CbGbCtD
Icosapent—PTGS1—Etoposide—lung cancer	0.0195	0.295	CbGbCtD
Icosapent—ACSL3—respiratory system—lung cancer	0.0112	0.0938	CbGeAlD
Icosapent—FABP7—mammary gland—lung cancer	0.0103	0.0858	CbGeAlD
Icosapent—PPARD—mammary gland—lung cancer	0.00811	0.0679	CbGeAlD
Icosapent—ACSL3—lung—lung cancer	0.00596	0.0498	CbGeAlD
Icosapent—ACSL4—respiratory system—lung cancer	0.00563	0.0471	CbGeAlD
Icosapent—TRPV1—epithelium—lung cancer	0.00518	0.0433	CbGeAlD
Icosapent—FADS1—bronchus—lung cancer	0.0051	0.0427	CbGeAlD
Icosapent—ACSL4—bronchus—lung cancer	0.00463	0.0388	CbGeAlD
Icosapent—FADS1—trachea—lung cancer	0.00458	0.0383	CbGeAlD
Icosapent—FADS1—cardiac atrium—lung cancer	0.0043	0.036	CbGeAlD
Icosapent—ACSL4—trachea—lung cancer	0.00416	0.0348	CbGeAlD
Icosapent—ACSL4—cardiac atrium—lung cancer	0.00391	0.0327	CbGeAlD
Icosapent—PPARG—mammary gland—lung cancer	0.0038	0.0318	CbGeAlD
Icosapent—FADS1—bone marrow—lung cancer	0.00363	0.0304	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Crizotinib—lung cancer	0.00353	0.0231	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Crizotinib—lung cancer	0.00345	0.0226	CcSEcCtD
Icosapent—ACSL4—bone marrow—lung cancer	0.0033	0.0276	CbGeAlD
Icosapent—FADS1—lung—lung cancer	0.00329	0.0275	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Pemetrexed—lung cancer	0.00322	0.0211	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Gefitinib—lung cancer	0.0032	0.021	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Pemetrexed—lung cancer	0.00316	0.0207	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Gefitinib—lung cancer	0.00314	0.0206	CcSEcCtD
Icosapent—ACSL4—lung—lung cancer	0.00299	0.025	CbGeAlD
Icosapent—PPARG—Irinotecan—Topotecan—lung cancer	0.00289	0.33	CbGdCrCtD
Icosapent—PPARD—lung—lung cancer	0.00287	0.024	CbGeAlD
Icosapent—PPARG—respiratory system—lung cancer	0.00253	0.0212	CbGeAlD
Icosapent—PPARG—Topotecan—Irinotecan—lung cancer	0.0024	0.274	CbGdCrCtD
Icosapent—PPARG—Etoposide—Teniposide—lung cancer	0.00238	0.272	CbGdCrCtD
Icosapent—Malnutrition—Crizotinib—lung cancer	0.00236	0.0155	CcSEcCtD
Icosapent—Dysgeusia—Crizotinib—lung cancer	0.00231	0.0151	CcSEcCtD
Icosapent—FADS1—lymph node—lung cancer	0.00225	0.0188	CbGeAlD
Icosapent—Malnutrition—Pemetrexed—lung cancer	0.00216	0.0141	CcSEcCtD
Icosapent—Malnutrition—Gefitinib—lung cancer	0.00214	0.014	CcSEcCtD
Icosapent—PPARG—epithelium—lung cancer	0.00212	0.0177	CbGeAlD
Icosapent—Dysgeusia—Pemetrexed—lung cancer	0.00211	0.0138	CcSEcCtD
Icosapent—ACSL4—lymph node—lung cancer	0.00204	0.0171	CbGeAlD
Icosapent—PPARD—lymph node—lung cancer	0.00196	0.0164	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Topotecan—lung cancer	0.00194	0.0127	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Topotecan—lung cancer	0.0019	0.0124	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Erlotinib—lung cancer	0.00188	0.0123	CcSEcCtD
Icosapent—Oropharyngeal pain—Paclitaxel—lung cancer	0.00187	0.0123	CcSEcCtD
Icosapent—Arthralgia—Pemetrexed—lung cancer	0.00184	0.012	CcSEcCtD
Icosapent—Anaphylactic shock—Pemetrexed—lung cancer	0.00176	0.0115	CcSEcCtD
Icosapent—Dyspepsia—Crizotinib—lung cancer	0.00169	0.0111	CcSEcCtD
Icosapent—Gastrointestinal disorder—Crizotinib—lung cancer	0.00166	0.0109	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Vinorelbine—lung cancer	0.00166	0.0108	CcSEcCtD
Icosapent—Constipation—Crizotinib—lung cancer	0.00165	0.0108	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Pemetrexed—lung cancer	0.0016	0.0105	CcSEcCtD
Icosapent—Oropharyngeal pain—Docetaxel—lung cancer	0.00159	0.0104	CcSEcCtD
Icosapent—Dyspepsia—Pemetrexed—lung cancer	0.00155	0.0101	CcSEcCtD
Icosapent—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00152	0.00995	CcSEcCtD
Icosapent—Gastrointestinal disorder—Gefitinib—lung cancer	0.00151	0.00989	CcSEcCtD
Icosapent—Constipation—Pemetrexed—lung cancer	0.0015	0.00986	CcSEcCtD
Icosapent—Constipation—Gefitinib—lung cancer	0.00149	0.00979	CcSEcCtD
Icosapent—PPARG—bone marrow—lung cancer	0.00148	0.0124	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Irinotecan—lung cancer	0.00137	0.00895	CcSEcCtD
Icosapent—PTGS1—respiratory system—lung cancer	0.00135	0.0113	CbGeAlD
Icosapent—PPARG—lung—lung cancer	0.00134	0.0113	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Gemcitabine—lung cancer	0.00133	0.00871	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Gemcitabine—lung cancer	0.0013	0.00853	CcSEcCtD
Icosapent—PTGS2—respiratory system—lung cancer	0.00129	0.0108	CbGeAlD
Icosapent—Malnutrition—Topotecan—lung cancer	0.00129	0.00848	CcSEcCtD
Icosapent—Malnutrition—Erlotinib—lung cancer	0.00128	0.00839	CcSEcCtD
Icosapent—Pruritus—Pemetrexed—lung cancer	0.00124	0.00816	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Cisplatin—lung cancer	0.00124	0.00812	CcSEcCtD
Icosapent—Pruritus—Gefitinib—lung cancer	0.00124	0.0081	CcSEcCtD
Icosapent—Vomiting—Crizotinib—lung cancer	0.00122	0.00802	CcSEcCtD
Icosapent—Rash—Crizotinib—lung cancer	0.00121	0.00795	CcSEcCtD
Icosapent—Dermatitis—Crizotinib—lung cancer	0.00121	0.00795	CcSEcCtD
Icosapent—PTGS1—epithelium—lung cancer	0.00113	0.00947	CbGeAlD
Icosapent—Vomiting—Pemetrexed—lung cancer	0.00112	0.00733	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Paclitaxel—lung cancer	0.00111	0.0073	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Etoposide—lung cancer	0.00111	0.00729	CcSEcCtD
Icosapent—Vomiting—Gefitinib—lung cancer	0.00111	0.00728	CcSEcCtD
Icosapent—Rash—Pemetrexed—lung cancer	0.00111	0.00727	CcSEcCtD
Icosapent—Dermatitis—Pemetrexed—lung cancer	0.00111	0.00726	CcSEcCtD
Icosapent—Malnutrition—Vinorelbine—lung cancer	0.00111	0.00725	CcSEcCtD
Icosapent—Rash—Gefitinib—lung cancer	0.0011	0.00722	CcSEcCtD
Icosapent—Arthralgia—Topotecan—lung cancer	0.0011	0.00722	CcSEcCtD
Icosapent—Dermatitis—Gefitinib—lung cancer	0.0011	0.00722	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Paclitaxel—lung cancer	0.00109	0.00715	CcSEcCtD
Icosapent—Arthralgia—Erlotinib—lung cancer	0.00109	0.00714	CcSEcCtD
Icosapent—PTGS2—epithelium—lung cancer	0.00108	0.00905	CbGeAlD
Icosapent—PPARG—Teniposide—Etoposide—lung cancer	0.00108	0.124	CbGdCrCtD
Icosapent—PTGS2—bronchus—lung cancer	0.00107	0.00891	CbGeAlD
Icosapent—Anaphylactic shock—Topotecan—lung cancer	0.00106	0.00692	CcSEcCtD
Icosapent—Pruritus—Teniposide—lung cancer	0.00101	0.00661	CcSEcCtD
Icosapent—PTGS1—trachea—lung cancer	0.001	0.00837	CbGeAlD
Icosapent—Musculoskeletal discomfort—Topotecan—lung cancer	0.000962	0.00631	CcSEcCtD
Icosapent—PTGS2—trachea—lung cancer	0.000957	0.008	CbGeAlD
Icosapent—Musculoskeletal discomfort—Erlotinib—lung cancer	0.000952	0.00624	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Docetaxel—lung cancer	0.000944	0.00618	CcSEcCtD
Icosapent—Arthralgia—Vinorelbine—lung cancer	0.000943	0.00618	CcSEcCtD
Icosapent—PTGS1—cardiac atrium—lung cancer	0.00094	0.00786	CbGeAlD
Icosapent—Constipation—Vinblastine—lung cancer	0.00093	0.00609	CcSEcCtD
Icosapent—Dyspepsia—Topotecan—lung cancer	0.00093	0.00609	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Docetaxel—lung cancer	0.000924	0.00606	CcSEcCtD
Icosapent—Dyspepsia—Erlotinib—lung cancer	0.00092	0.00603	CcSEcCtD
Icosapent—PPARG—lymph node—lung cancer	0.00092	0.0077	CbGeAlD
Icosapent—Gastrointestinal disorder—Topotecan—lung cancer	0.000912	0.00597	CcSEcCtD
Icosapent—Vomiting—Teniposide—lung cancer	0.000906	0.00594	CcSEcCtD
Icosapent—Anaphylactic shock—Vinorelbine—lung cancer	0.000904	0.00592	CcSEcCtD
Icosapent—Constipation—Topotecan—lung cancer	0.000903	0.00592	CcSEcCtD
Icosapent—Gastrointestinal disorder—Erlotinib—lung cancer	0.000902	0.00591	CcSEcCtD
Icosapent—Rash—Teniposide—lung cancer	0.000899	0.00589	CcSEcCtD
Icosapent—Dermatitis—Teniposide—lung cancer	0.000898	0.00588	CcSEcCtD
Icosapent—Constipation—Erlotinib—lung cancer	0.000894	0.00586	CcSEcCtD
Icosapent—Eructation—Doxorubicin—lung cancer	0.000885	0.0058	CcSEcCtD
Icosapent—Malnutrition—Cisplatin—lung cancer	0.000829	0.00543	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000823	0.00539	CcSEcCtD
Icosapent—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00078	0.00511	CcSEcCtD
Icosapent—Constipation—Vinorelbine—lung cancer	0.000773	0.00506	CcSEcCtD
Icosapent—PTGS2—bone marrow—lung cancer	0.000759	0.00635	CbGeAlD
Icosapent—Arthralgia—Gemcitabine—lung cancer	0.000757	0.00496	CcSEcCtD
Icosapent—Pruritus—Topotecan—lung cancer	0.000747	0.0049	CcSEcCtD
Icosapent—Anaphylactic shock—Irinotecan—lung cancer	0.000745	0.00488	CcSEcCtD
Icosapent—Malnutrition—Paclitaxel—lung cancer	0.000745	0.00488	CcSEcCtD
Icosapent—Dysgeusia—Etoposide—lung cancer	0.000744	0.00487	CcSEcCtD
Icosapent—Pruritus—Erlotinib—lung cancer	0.000739	0.00484	CcSEcCtD
Icosapent—Dysgeusia—Paclitaxel—lung cancer	0.000729	0.00478	CcSEcCtD
Icosapent—Anaphylactic shock—Gemcitabine—lung cancer	0.000726	0.00476	CcSEcCtD
Icosapent—PTGS1—lung—lung cancer	0.000719	0.00602	CbGeAlD
Icosapent—Vomiting—Vinblastine—lung cancer	0.000691	0.00453	CcSEcCtD
Icosapent—PTGS2—lung—lung cancer	0.000687	0.00575	CbGeAlD
Icosapent—Anaphylactic shock—Cisplatin—lung cancer	0.000677	0.00443	CcSEcCtD
Icosapent—Vomiting—Topotecan—lung cancer	0.000672	0.0044	CcSEcCtD
Icosapent—Rash—Topotecan—lung cancer	0.000666	0.00436	CcSEcCtD
Icosapent—Dermatitis—Topotecan—lung cancer	0.000665	0.00436	CcSEcCtD
Icosapent—Vomiting—Erlotinib—lung cancer	0.000664	0.00435	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000661	0.00433	CcSEcCtD
Icosapent—Rash—Erlotinib—lung cancer	0.000659	0.00432	CcSEcCtD
Icosapent—Dermatitis—Erlotinib—lung cancer	0.000658	0.00431	CcSEcCtD
Icosapent—Dyspepsia—Irinotecan—lung cancer	0.000656	0.0043	CcSEcCtD
Icosapent—Gastrointestinal disorder—Irinotecan—lung cancer	0.000643	0.00422	CcSEcCtD
Icosapent—Pruritus—Vinorelbine—lung cancer	0.000639	0.00419	CcSEcCtD
Icosapent—Constipation—Irinotecan—lung cancer	0.000637	0.00418	CcSEcCtD
Icosapent—Arthralgia—Paclitaxel—lung cancer	0.000634	0.00415	CcSEcCtD
Icosapent—Malnutrition—Docetaxel—lung cancer	0.000631	0.00414	CcSEcCtD
Icosapent—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000627	0.00411	CcSEcCtD
Icosapent—Constipation—Gemcitabine—lung cancer	0.000621	0.00407	CcSEcCtD
Icosapent—Anaphylactic shock—Etoposide—lung cancer	0.00062	0.00406	CcSEcCtD
Icosapent—Dysgeusia—Docetaxel—lung cancer	0.000618	0.00405	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000616	0.00404	CcSEcCtD
Icosapent—Anaphylactic shock—Paclitaxel—lung cancer	0.000608	0.00398	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000589	0.00386	CcSEcCtD
Icosapent—Gastrointestinal disorder—Cisplatin—lung cancer	0.000584	0.00383	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000577	0.00378	CcSEcCtD
Icosapent—Vomiting—Vinorelbine—lung cancer	0.000574	0.00376	CcSEcCtD
Icosapent—Rash—Vinorelbine—lung cancer	0.00057	0.00373	CcSEcCtD
Icosapent—Dermatitis—Vinorelbine—lung cancer	0.000569	0.00373	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000554	0.00363	CcSEcCtD
Icosapent—Arthralgia—Docetaxel—lung cancer	0.000537	0.00352	CcSEcCtD
Icosapent—Gastrointestinal disorder—Etoposide—lung cancer	0.000535	0.00351	CcSEcCtD
Icosapent—Dyspepsia—Paclitaxel—lung cancer	0.000535	0.00351	CcSEcCtD
Icosapent—Constipation—Etoposide—lung cancer	0.00053	0.00347	CcSEcCtD
Icosapent—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000525	0.00344	CcSEcCtD
Icosapent—Constipation—Paclitaxel—lung cancer	0.00052	0.00341	CcSEcCtD
Icosapent—Anaphylactic shock—Docetaxel—lung cancer	0.000515	0.00338	CcSEcCtD
Icosapent—Pruritus—Gemcitabine—lung cancer	0.000514	0.00336	CcSEcCtD
Icosapent—PTGS1—lymph node—lung cancer	0.000492	0.00411	CbGeAlD
Icosapent—Vomiting—Irinotecan—lung cancer	0.000474	0.0031	CcSEcCtD
Icosapent—PTGS2—lymph node—lung cancer	0.00047	0.00393	CbGeAlD
Icosapent—Rash—Irinotecan—lung cancer	0.00047	0.00308	CcSEcCtD
Icosapent—Dermatitis—Irinotecan—lung cancer	0.000469	0.00308	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000469	0.00308	CcSEcCtD
Icosapent—Vomiting—Gemcitabine—lung cancer	0.000462	0.00302	CcSEcCtD
Icosapent—Rash—Gemcitabine—lung cancer	0.000458	0.003	CcSEcCtD
Icosapent—Dermatitis—Gemcitabine—lung cancer	0.000457	0.003	CcSEcCtD
Icosapent—Malnutrition—Methotrexate—lung cancer	0.000455	0.00298	CcSEcCtD
Icosapent—Dyspepsia—Docetaxel—lung cancer	0.000453	0.00297	CcSEcCtD
Icosapent—Dysgeusia—Methotrexate—lung cancer	0.000445	0.00292	CcSEcCtD
Icosapent—Dihomo-gamma-linolenic acid—PTGS2—lung cancer	0.000445	1	CrCbGaD
Icosapent—Gastrointestinal disorder—Docetaxel—lung cancer	0.000445	0.00291	CcSEcCtD
Icosapent—Constipation—Docetaxel—lung cancer	0.000441	0.00289	CcSEcCtD
Icosapent—Pruritus—Etoposide—lung cancer	0.000439	0.00287	CcSEcCtD
Icosapent—Vomiting—Cisplatin—lung cancer	0.00043	0.00282	CcSEcCtD
Icosapent—Pruritus—Paclitaxel—lung cancer	0.00043	0.00282	CcSEcCtD
Icosapent—Rash—Cisplatin—lung cancer	0.000427	0.0028	CcSEcCtD
Icosapent—Dermatitis—Cisplatin—lung cancer	0.000426	0.00279	CcSEcCtD
Icosapent—Vomiting—Etoposide—lung cancer	0.000394	0.00258	CcSEcCtD
Icosapent—Malnutrition—Doxorubicin—lung cancer	0.000394	0.00258	CcSEcCtD
Icosapent—Rash—Etoposide—lung cancer	0.000391	0.00256	CcSEcCtD
Icosapent—Dermatitis—Etoposide—lung cancer	0.00039	0.00256	CcSEcCtD
Icosapent—Arthralgia—Methotrexate—lung cancer	0.000387	0.00254	CcSEcCtD
Icosapent—Vomiting—Paclitaxel—lung cancer	0.000386	0.00253	CcSEcCtD
Icosapent—Dysgeusia—Doxorubicin—lung cancer	0.000386	0.00253	CcSEcCtD
Icosapent—Rash—Paclitaxel—lung cancer	0.000383	0.00251	CcSEcCtD
Icosapent—Dermatitis—Paclitaxel—lung cancer	0.000383	0.00251	CcSEcCtD
Icosapent—Anaphylactic shock—Methotrexate—lung cancer	0.000371	0.00243	CcSEcCtD
Icosapent—Pruritus—Docetaxel—lung cancer	0.000364	0.00239	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000338	0.00222	CcSEcCtD
Icosapent—Arthralgia—Doxorubicin—lung cancer	0.000335	0.0022	CcSEcCtD
Icosapent—Vomiting—Docetaxel—lung cancer	0.000328	0.00215	CcSEcCtD
Icosapent—Dyspepsia—Methotrexate—lung cancer	0.000327	0.00214	CcSEcCtD
Icosapent—Rash—Docetaxel—lung cancer	0.000325	0.00213	CcSEcCtD
Icosapent—Dermatitis—Docetaxel—lung cancer	0.000324	0.00213	CcSEcCtD
Icosapent—Anaphylactic shock—Doxorubicin—lung cancer	0.000321	0.00211	CcSEcCtD
Icosapent—Gastrointestinal disorder—Methotrexate—lung cancer	0.000321	0.0021	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000293	0.00192	CcSEcCtD
Icosapent—Dyspepsia—Doxorubicin—lung cancer	0.000283	0.00185	CcSEcCtD
Icosapent—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000278	0.00182	CcSEcCtD
Icosapent—Constipation—Doxorubicin—lung cancer	0.000275	0.0018	CcSEcCtD
Icosapent—Pruritus—Methotrexate—lung cancer	0.000263	0.00172	CcSEcCtD
Icosapent—Vomiting—Methotrexate—lung cancer	0.000236	0.00155	CcSEcCtD
Icosapent—Rash—Methotrexate—lung cancer	0.000234	0.00153	CcSEcCtD
Icosapent—Dermatitis—Methotrexate—lung cancer	0.000234	0.00153	CcSEcCtD
Icosapent—Pruritus—Doxorubicin—lung cancer	0.000227	0.00149	CcSEcCtD
Icosapent—Vomiting—Doxorubicin—lung cancer	0.000204	0.00134	CcSEcCtD
Icosapent—Rash—Doxorubicin—lung cancer	0.000203	0.00133	CcSEcCtD
Icosapent—Dermatitis—Doxorubicin—lung cancer	0.000203	0.00133	CcSEcCtD
Icosapent—FFAR1—Signaling Pathways—CASP3—lung cancer	3.43e-05	0.000128	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL2—lung cancer	3.43e-05	0.000127	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ABCC3—lung cancer	3.41e-05	0.000127	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL6—lung cancer	3.41e-05	0.000127	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	3.37e-05	0.000125	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCND1—lung cancer	3.34e-05	0.000124	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—JUN—lung cancer	3.33e-05	0.000124	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKR1C1—lung cancer	3.31e-05	0.000123	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	3.28e-05	0.000122	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CG—lung cancer	3.27e-05	0.000122	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL6—lung cancer	3.25e-05	0.000121	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MMP9—lung cancer	3.24e-05	0.00012	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CDKN1A—lung cancer	3.23e-05	0.00012	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PTEN—lung cancer	3.22e-05	0.00012	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—UGT1A1—lung cancer	3.21e-05	0.000119	CbGpPWpGaD
Icosapent—PTGS2—Disease—PXN—lung cancer	3.2e-05	0.000119	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	3.2e-05	0.000119	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTA3—lung cancer	3.19e-05	0.000118	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—RRM1—lung cancer	3.19e-05	0.000118	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP2E1—lung cancer	3.18e-05	0.000118	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—AKT1—lung cancer	3.15e-05	0.000117	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NQO1—lung cancer	3.14e-05	0.000117	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKR1C1—lung cancer	3.13e-05	0.000116	CbGpPWpGaD
Icosapent—PPARD—Metabolism—POMC—lung cancer	3.12e-05	0.000116	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GNG11—lung cancer	3.09e-05	0.000115	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.08e-05	0.000114	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.07e-05	0.000114	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EP300—lung cancer	3.07e-05	0.000114	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.05e-05	0.000113	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CREBBP—lung cancer	3.03e-05	0.000113	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.02e-05	0.000112	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PIK3CA—lung cancer	3.01e-05	0.000112	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—B4GALT5—lung cancer	3e-05	0.000111	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP9—lung cancer	2.99e-05	0.000111	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SRC—lung cancer	2.99e-05	0.000111	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALDOA—lung cancer	2.95e-05	0.000109	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.94e-05	0.000109	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—AKT1—lung cancer	2.93e-05	0.000109	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTA4—lung cancer	2.92e-05	0.000108	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—VEGFA—lung cancer	2.91e-05	0.000108	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ERCC2—lung cancer	2.91e-05	0.000108	CbGpPWpGaD
Icosapent—PTGS2—Disease—NPPA—lung cancer	2.88e-05	0.000107	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—STAT3—lung cancer	2.88e-05	0.000107	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CD—lung cancer	2.88e-05	0.000107	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NRAS—lung cancer	2.88e-05	0.000107	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2.88e-05	0.000107	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NCOA3—lung cancer	2.86e-05	0.000106	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.85e-05	0.000106	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTA2—lung cancer	2.84e-05	0.000106	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ALB—lung cancer	2.84e-05	0.000106	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EP300—lung cancer	2.84e-05	0.000105	CbGpPWpGaD
Icosapent—PPARG—Metabolism—STK11—lung cancer	2.83e-05	0.000105	CbGpPWpGaD
Icosapent—PTGS2—Disease—PPIA—lung cancer	2.82e-05	0.000105	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.81e-05	0.000104	CbGpPWpGaD
Icosapent—PTGS2—Disease—ALDOA—lung cancer	2.79e-05	0.000104	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ADCY1—lung cancer	2.78e-05	0.000103	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ABCG2—lung cancer	2.78e-05	0.000103	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—SRC—lung cancer	2.76e-05	0.000103	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MAPK3—lung cancer	2.75e-05	0.000102	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTA1—lung cancer	2.74e-05	0.000102	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ENO2—lung cancer	2.73e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HPGDS—lung cancer	2.73e-05	0.000101	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PIK3CA—lung cancer	2.72e-05	0.000101	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PIK3CA—lung cancer	2.72e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	2.72e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPP2R1B—lung cancer	2.71e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ABCC3—lung cancer	2.71e-05	0.000101	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—VEGFA—lung cancer	2.69e-05	9.98e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MYC—lung cancer	2.68e-05	9.96e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.68e-05	9.94e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—STAT3—lung cancer	2.66e-05	9.89e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.66e-05	9.87e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NRAS—lung cancer	2.65e-05	9.86e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTT1—lung cancer	2.65e-05	9.83e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ADCY1—lung cancer	2.64e-05	9.8e-05	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—MYC—lung cancer	2.63e-05	9.76e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKR1C1—lung cancer	2.62e-05	9.75e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EGFR—lung cancer	2.62e-05	9.74e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTP1—lung cancer	2.62e-05	9.73e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GCLC—lung cancer	2.62e-05	9.72e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP2A6—lung cancer	2.62e-05	9.72e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.61e-05	9.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ENO2—lung cancer	2.59e-05	9.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PPP2R1B—lung cancer	2.57e-05	9.55e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SMARCA4—lung cancer	2.57e-05	9.55e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CAT—lung cancer	2.55e-05	9.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—UGT1A1—lung cancer	2.55e-05	9.47e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MAPK3—lung cancer	2.54e-05	9.45e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.53e-05	9.41e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CB—lung cancer	2.51e-05	9.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	2.5e-05	9.27e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTGS2—lung cancer	2.49e-05	9.23e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ENO1—lung cancer	2.48e-05	9.22e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ABCB1—lung cancer	2.48e-05	9.21e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KRAS—lung cancer	2.48e-05	9.2e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.47e-05	9.18e-05	CbGpPWpGaD
Icosapent—FADS1—Metabolism—AKT1—lung cancer	2.46e-05	9.13e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GNG11—lung cancer	2.46e-05	9.13e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.44e-05	9.08e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.44e-05	9.06e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TYMS—lung cancer	2.43e-05	9.05e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EGFR—lung cancer	2.42e-05	8.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.42e-05	8.97e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTM1—lung cancer	2.41e-05	8.94e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MAPK3—lung cancer	2.38e-05	8.85e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ENO1—lung cancer	2.35e-05	8.74e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALDOA—lung cancer	2.34e-05	8.69e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MYC—lung cancer	2.32e-05	8.61e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KRAS—lung cancer	2.28e-05	8.49e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP1A1—lung cancer	2.28e-05	8.48e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PIK3CA—lung cancer	2.27e-05	8.45e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NCOA3—lung cancer	2.27e-05	8.44e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ERCC2—lung cancer	2.26e-05	8.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.23e-05	8.29e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP2E1—lung cancer	2.22e-05	8.27e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—AKT1—lung cancer	2.22e-05	8.26e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—AKT1—lung cancer	2.22e-05	8.26e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ADCY1—lung cancer	2.21e-05	8.21e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ABCG2—lung cancer	2.21e-05	8.21e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TP53—lung cancer	2.2e-05	8.18e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NQO1—lung cancer	2.2e-05	8.17e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APP—lung cancer	2.19e-05	8.12e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGF9—lung cancer	2.17e-05	8.05e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTEN—lung cancer	2.17e-05	8.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ENO2—lung cancer	2.17e-05	8.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HPGDS—lung cancer	2.17e-05	8.05e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.15e-05	8e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPP2R1B—lung cancer	2.15e-05	8e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.13e-05	7.93e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—CREBBP—lung cancer	2.13e-05	7.92e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.12e-05	7.89e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRAS—lung cancer	2.1e-05	7.82e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTT1—lung cancer	2.1e-05	7.81e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP2A6—lung cancer	2.08e-05	7.72e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GCLC—lung cancer	2.08e-05	7.72e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—JUNB—lung cancer	2.07e-05	7.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.07e-05	7.69e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—EP300—lung cancer	2.07e-05	7.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.04e-05	7.58e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL6—lung cancer	2.01e-05	7.48e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—STK11—lung cancer	1.98e-05	7.37e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ENO1—lung cancer	1.97e-05	7.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.96e-05	7.29e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—APOA1—lung cancer	1.96e-05	7.27e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—HRAS—lung cancer	1.94e-05	7.21e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.94e-05	7.2e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.87e-05	6.96e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.86e-05	6.92e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6—lung cancer	1.86e-05	6.91e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—AKT1—lung cancer	1.86e-05	6.9e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTP1—lung cancer	1.83e-05	6.82e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FOXO3—lung cancer	1.81e-05	6.74e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CG—lung cancer	1.79e-05	6.64e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CAT—lung cancer	1.79e-05	6.63e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.78e-05	6.6e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP2E1—lung cancer	1.77e-05	6.56e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NQO1—lung cancer	1.75e-05	6.49e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ABCB1—lung cancer	1.74e-05	6.45e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—AKT1—lung cancer	1.71e-05	6.37e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.71e-05	6.35e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TYMS—lung cancer	1.71e-05	6.34e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—POMC—lung cancer	1.7e-05	6.32e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTM1—lung cancer	1.69e-05	6.26e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CREBBP—lung cancer	1.66e-05	6.16e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HES1—lung cancer	1.61e-05	5.97e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—AKT1—lung cancer	1.61e-05	5.97e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP1A1—lung cancer	1.6e-05	5.94e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ERCC2—lung cancer	1.59e-05	5.89e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—STK11—lung cancer	1.57e-05	5.85e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CD—lung cancer	1.57e-05	5.84e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ALB—lung cancer	1.55e-05	5.76e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CA—lung cancer	1.53e-05	5.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERCC2—lung cancer	1.5e-05	5.58e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.48e-05	5.49e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB3—lung cancer	1.47e-05	5.46e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTP1—lung cancer	1.46e-05	5.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CAT—lung cancer	1.42e-05	5.27e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.41e-05	5.24e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—TERT—lung cancer	1.41e-05	5.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ABCB1—lung cancer	1.38e-05	5.12e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—APOA1—lung cancer	1.37e-05	5.1e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CB—lung cancer	1.37e-05	5.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGFR1—lung cancer	1.37e-05	5.08e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTGS2—lung cancer	1.36e-05	5.04e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TYMS—lung cancer	1.35e-05	5.03e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HIF1A—lung cancer	1.35e-05	5e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTM1—lung cancer	1.34e-05	4.97e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.31e-05	4.88e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MAPK3—lung cancer	1.3e-05	4.83e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APOA1—lung cancer	1.3e-05	4.83e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP1A1—lung cancer	1.27e-05	4.71e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MYC—lung cancer	1.26e-05	4.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ERCC2—lung cancer	1.26e-05	4.68e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CG—lung cancer	1.25e-05	4.65e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AKT1—lung cancer	1.25e-05	4.64e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—POMC—lung cancer	1.19e-05	4.43e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—KIT—lung cancer	1.19e-05	4.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APC—lung cancer	1.19e-05	4.41e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTEN—lung cancer	1.18e-05	4.4e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGF—lung cancer	1.17e-05	4.36e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CREBBP—lung cancer	1.16e-05	4.31e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—EP300—lung cancer	1.13e-05	4.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—BRAF—lung cancer	1.12e-05	4.14e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6R—lung cancer	1.1e-05	4.09e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CD—lung cancer	1.1e-05	4.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CREBBP—lung cancer	1.1e-05	4.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—APOA1—lung cancer	1.09e-05	4.04e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALB—lung cancer	1.09e-05	4.04e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MAP2K1—lung cancer	1.05e-05	3.9e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CD—lung cancer	1.04e-05	3.88e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.04e-05	3.87e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CG—lung cancer	9.94e-06	3.69e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CB—lung cancer	9.59e-06	3.56e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTGS2—lung cancer	9.51e-06	3.53e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—POMC—lung cancer	9.46e-06	3.51e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MDM2—lung cancer	9.35e-06	3.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RAF1—lung cancer	9.31e-06	3.46e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CREBBP—lung cancer	9.21e-06	3.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB2—lung cancer	9.21e-06	3.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CB—lung cancer	9.09e-06	3.38e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTOR—lung cancer	9.09e-06	3.38e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD4—lung cancer	9.08e-06	3.37e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—AKT1—lung cancer	8.77e-06	3.26e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CD—lung cancer	8.74e-06	3.25e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALB—lung cancer	8.63e-06	3.2e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CA—lung cancer	8.35e-06	3.1e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTEN—lung cancer	8.29e-06	3.08e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—EP300—lung cancer	7.91e-06	2.94e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN1A—lung cancer	7.88e-06	2.93e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PTEN—lung cancer	7.86e-06	2.92e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CB—lung cancer	7.62e-06	2.83e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EP300—lung cancer	7.49e-06	2.78e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SRC—lung cancer	7.29e-06	2.71e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—STAT3—lung cancer	7.03e-06	2.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NRAS—lung cancer	7.01e-06	2.6e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKT1—lung cancer	6.82e-06	2.53e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MAPK3—lung cancer	6.71e-06	2.49e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PTEN—lung cancer	6.58e-06	2.44e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MYC—lung cancer	6.53e-06	2.43e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGFR—lung cancer	6.39e-06	2.37e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—EP300—lung cancer	6.28e-06	2.33e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—KRAS—lung cancer	6.03e-06	2.24e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CA—lung cancer	5.85e-06	2.17e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CA—lung cancer	5.54e-06	2.06e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HRAS—lung cancer	5.13e-06	1.91e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6—lung cancer	4.91e-06	1.82e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKT1—lung cancer	4.78e-06	1.77e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CA—lung cancer	4.64e-06	1.72e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT1—lung cancer	4.53e-06	1.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKT1—lung cancer	3.79e-06	1.41e-05	CbGpPWpGaD
